ÂÌñÉç

How big is the Cholera Vaccine Market | Key Players & Global Health Demand 2025

Code: MTA5310 Publication Date: Jul 2025

How big is the Cholera Vaccine Market?

According to ÂÌñÉç internal database and industry insights, the Global cholera vaccine market was valued at approximately USD 95 million in 2024 and is projected to reach USD 138 million by 2031, growing at a CAGR of 5.5%.

This growth is driven by increasing outbreaks in vulnerable regions, global immunization programs, and rising awareness about waterborne disease prevention.

Key Growth Drivers of the Cholera Vaccine Market

  • Rising incidence of cholera outbreaks in low- and middle-income countries
  • Expansion of government and WHO-backed vaccination campaigns
  • Growing travel-related demand for oral cholera vaccines
  • Advancements in vaccine formulations and long-term protection
  • Increased funding and support from international health organizations

Cholera Vaccine Market Trends

The cholera vaccine market is witnessing growth due to heightened focus on preventive healthcare and public health security. Oral vaccines are gaining popularity due to ease of administration and improved compliance. There's an increasing shift toward stockpiling and preemptive vaccination in high-risk areas. Manufacturers are working on thermostable vaccines suitable for remote deployment. Asia and Africa remain the most active regions due to recurring outbreaks and high demand for affordable immunization solutions.

Emerging Developments in the Cholera Vaccine Market

Recent developments in the cholera vaccine market include investments in next-generation oral vaccines with broader efficacy and simplified logistics. Single dose regimens and long shelf life are the areas of manufacturer interest in order to facilitate transportation in resource scarce environments. International collaboration and the cooperation of NGOs and public health agencies are currently extending the range of vaccines. Moreover, combined waterborne disease vaccines are also subject to research in order to make it more delivered in the endemic regions.

Major Companies in the Cholera Vaccine Market

  • Valneva SE
  • EU Biologics Co., Ltd.
  • Shantha Biotechnics (a Sanofi company)
  • PaxVax (Emergent BioSolutions)
  • Bharat Biotech
  • Johnson & Johnson
  • Aurobindo Pharma
  • Hilleman Laboratories
  • Biological E. Limited
  • GlaxoSmithKline plc
How big is the Cholera Vaccine Market : FAQ's
The cholera vaccine market was valued at USD 95 million in 2024 and is projected to reach USD 138 million by 2031.
The cholera vaccine market is expected to grow at a CAGR of 5.5% between 2025 and 2031.
Public immunization programs, traveler vaccines, humanitarian aid, and emergency stockpiles.
Global rise in cholera cases, preventive health policies, and expanded vaccination campaigns.
Cold chain logistics, limited access in rural regions, regulatory hurdles, and inconsistent funding.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
ÂÌñÉç Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All